Page last updated: 2024-10-28

guanfacine and Adverse Drug Event

guanfacine has been researched along with Adverse Drug Event in 7 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Research Excerpts

ExcerptRelevanceReference
" Trials of amphetamines, atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with a placebo arm and reporting data on headache as an adverse event, were included."2.82Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. ( Banaschewski, T; Bölte, S; Buitelaar, JK; Coghill, D; Cortese, S; Häge, A; Hohmann, S; Jonsson, U; Nobel Norrman, H; Pan, PY; Şahpazoğlu Çakmak, SS, 2022)
"5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects."1.32Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Matthews, EJ1
Kruhlak, NL1
Weaver, JL1
Benz, RD1
Contrera, JF1
Liu, Z1
Shi, Q1
Ding, D1
Kelly, R1
Fang, H1
Tong, W1
Morgan, RE1
van Staden, CJ1
Chen, Y1
Kalyanaraman, N1
Kalanzi, J1
Dunn, RT1
Afshari, CA1
Hamadeh, HK1
Pan, PY1
Jonsson, U1
Şahpazoğlu Çakmak, SS1
Häge, A1
Hohmann, S1
Nobel Norrman, H1
Buitelaar, JK1
Banaschewski, T1
Cortese, S1
Coghill, D1
Bölte, S1
Elliott, J1
Johnston, A1
Husereau, D1
Kelly, SE1
Eagles, C1
Charach, A1
Hsieh, SC1
Bai, Z1
Hossain, A1
Skidmore, B1
Tsakonas, E1
Chojecki, D1
Mamdani, M1
Wells, GA1
Hasan, SS1
Bal, N1
Baker, I1
Kow, CS1
Khan, MU1
Duong, S1
Chung, K1
Wigal, SB1

Reviews

3 reviews available for guanfacine and Adverse Drug Event

ArticleYear
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.
    Psychological medicine, 2022, Volume: 52, Issue:1

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2022
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes

2020
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:5

    Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nerv

2012

Other Studies

4 other studies available for guanfacine and Adverse Drug Event

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru

2004
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily

2013
Adverse Drug Reaction Reporting and Prescribing Trends of Drugs for Attention Deficit Hyperactivity Disorder in Primary Care England, 2010-2019.
    Journal of attention disorders, 2022, Volume: 26, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Databases, Factual; Drug-Related Side Effects and Adv

2022